TapewireFind a company

organization · Reporting owner

Funicular Fund, LP

Disclosed activity across 2 companies

Tapewire entity
126946
SEC CIK
0001752618

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Oruka Therapeutics, Inc.ABIO · Entity 3781See Footnote 1May 23, 2022May 25, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Oruka Therapeutics, Inc.

Report date May 23, 2022 · Filed May 25, 2022

Jointly reported with Ma-Weaver Jacob

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect2,580,452 Last balance in matching sequence After 2022-05-25 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 1 · 2022-05-23 · Purchase · Acquired 2,301 · Balance 2,497,491

F1: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Row 2 · 2022-05-24 · Purchase · Acquired 18,110 · Balance 2,515,601

F1: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2850 to $2.2950, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F2: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Row 3 · 2022-05-25 · Purchase · Acquired 64,851 · Balance 2,580,452

F1: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2550 to $2.3450, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F2: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Put Option (obligation to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.50 · Expires 2022-12-16Direct14,500 Reported balance Holding disclosure · report date 2022-05-23 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance 14,500

F1: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

F3: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2850 to $2.2950, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F4: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2550 to $2.3450, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

BLOOMIA HOLDINGS, INC.

Report date October 21, 2020 · Filed October 22, 2020

Jointly reported with Cable Car Capital, LP

Section 16 reporting ended · disclosed 2020-10-22. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common stockSEC Table I · non-derivativeDirect1,357,799 Reported balance After 2020-10-21 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2020-10-21 · Sale · Disposed 225,000 · Balance 1,357,799

F1: Profits from the sale of 64,032 shares acquired within the preceding six months may be recoverable by the issuer in accordance with the procedures set forth in Section 16(b) of the Securities Exchange Act of 1934.

Common stockSEC Table I · non-derivativeDirect585,000 Reported balance After 2020-10-22 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2020-10-22 · Sale · Disposed 772,799 · Balance 585,000

Filing footnotes · ownership attribution and instrument terms

F1: Profits from the sale of 64,032 shares acquired within the preceding six months may be recoverable by the issuer in accordance with the procedures set forth in Section 16(b) of the Securities Exchange Act of 1934.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 25, 2022 Filed May 25, 2022 21:12 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 64,851 $2.32 $150,739.66
Disclosure

SEC source: 0000921895-22-001792 · form413392002_05252022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,580,452

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2550 to $2.3450, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 24, 2022 Filed May 25, 2022 21:12 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 18,110 $2.29 $41,383.16
Disclosure

SEC source: 0000921895-22-001792 · form413392002_05252022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,515,601

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2850 to $2.2950, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 23, 2022 Filed May 25, 2022 21:12 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 2,301 $2.30 $5,280.80
Disclosure

SEC source: 0000921895-22-001792 · form413392002_05252022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,497,491

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 19, 2022 Filed May 20, 2022 22:01 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 1 $2.25 $2.25
Disclosure

SEC source: 0000921895-22-001755 · form413392002_05202022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,495,190

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 18, 2022 Filed May 20, 2022 22:01 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 13,072 $2.30 $30,125.73
Disclosure

SEC source: 0000921895-22-001755 · form413392002_05202022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,495,189

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2850 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 16, 2022 Filed May 16, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 42,914 $2.30 $98,646.41
Disclosure

SEC source: 0000921895-22-001688 · form413392002_05162022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,482,117

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F5 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2400 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 13, 2022 Filed May 16, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 14,000 $2.29 $32,118.80
Disclosure

SEC source: 0000921895-22-001688 · form413392002_05162022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,439,203

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2550 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 12, 2022 Filed May 16, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 27,922 $2.27 $63,377.36
Disclosure

SEC source: 0000921895-22-001688 · form413392002_05162022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,425,203

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2650 to $2.2950, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 11, 2022 Filed May 11, 2022 22:38 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 24,596 $2.29 $56,201.86
Disclosure

SEC source: 0000921895-22-001599 · form413392002_05112022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,397,281

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:38 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 20,979 $2.28 $47,926.53
Disclosure

SEC source: 0000921895-22-001599 · form413392002_05112022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,372,685

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2750 to $2.2850, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 09, 2022 Filed May 9, 2022 21:44 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 49,221 $2.27 $111,721.83
Disclosure

SEC source: 0000921895-22-001519 · form413392002_05092022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,351,706

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F5 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2650 to $2.2750, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 06, 2022 Filed May 9, 2022 21:44 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 57,998 $2.28 $132,392.03
Disclosure

SEC source: 0000921895-22-001519 · form413392002_05092022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,302,485

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2600 to $2.2850, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 05, 2022 Filed May 9, 2022 21:44 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 16,903 $2.27 $38,449.25
Disclosure

SEC source: 0000921895-22-001519 · form413392002_05092022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,244,487

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2650 to $2.2750, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
May 02, 2022 Filed May 2, 2022 23:03 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 1,259 $2.32 $2,914.59
Disclosure

SEC source: 0000921895-22-001438 · form413392002_05022022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,227,584

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 29, 2022 Filed May 2, 2022 23:03 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 8,974 $2.30 $20,643.79
Disclosure

SEC source: 0000921895-22-001438 · form413392002_05022022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,226,325

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2750 to $2.3150, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 28, 2022 Filed May 2, 2022 23:03 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 23,381 $2.32 $54,171.44
Disclosure

SEC source: 0000921895-22-001438 · form413392002_05022022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,217,351

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2650 to $2.3250, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 22:33 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 SalePut Option (obligation to buy) · Derivative 7,500 $64.00 Strike: $2.50 $480,000.00
Disclosure

SEC source: 0000921895-22-001390 · form413392002_04272022.xml · derivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,500

Underlying: Common Stock · 1,450,000 shares

Expires 2022-12-16

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · security: The Fund wrote 7,500 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

F4 · price: The Fund wrote 7,500 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

F4 · ownership.direct: The Fund wrote 7,500 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 22:33 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 13,751 $2.29 $31,507.67
Disclosure

SEC source: 0000921895-22-001390 · form413392002_04272022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,193,970

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2750 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 19, 2022 Filed Apr 20, 2022 23:43 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 SalePut Option (obligation to buy) · Derivative 7,000 $64.00 Strike: $2.50 $448,000.00
Disclosure

SEC source: 0000921895-22-001318 · form413392002_04202022.xml · derivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 700,000 shares

Expires 2022-12-16

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · security: The Fund wrote 7,000 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

F4 · price: The Fund wrote 7,000 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

F4 · ownership.direct: The Fund wrote 7,000 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.

Read SEC document
April 18, 2022 Filed Apr 20, 2022 23:43 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 9,119 $2.31 $21,080.39
Disclosure

SEC source: 0000921895-22-001318 · form413392002_04202022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,180,219

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.3050 to $2.3150, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 00:04 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 17,410 $2.33 $40,546.15
Disclosure

SEC source: 0000921895-22-001257 · form413392002_04142022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,171,100

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.3050 to $2.3350, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 12, 2022 Filed Apr 12, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 69,398 $2.32 $161,100.52
Disclosure

SEC source: 0000921895-22-001225 · form413392002_04122022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,153,690

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.3050 to $2.3250, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F4 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 11, 2022 Filed Apr 12, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 4,655 $2.32 $10,776.33
Disclosure

SEC source: 0000921895-22-001225 · form413392002_04122022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,084,292

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 08, 2022 Filed Apr 12, 2022 23:31 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 30,660 $2.31 $70,852.19
Disclosure

SEC source: 0000921895-22-001225 · form413392002_04122022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,079,637

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.3050 to $2.3350, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F4 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 00:38 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 27,450 $2.32 $63,705.96
Disclosure

SEC source: 0000921895-22-001178 · form413392002_04072022.xml · nonDerivative · entry 3

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,048,977

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2950 to $2.3350, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F5 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 00:38 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 26,806 $2.30 $61,602.87
Disclosure

SEC source: 0000921895-22-001178 · form413392002_04072022.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,021,527

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2550 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F5 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 05, 2022 Filed Apr 8, 2022 00:38 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 49,728 $2.30 $114,468.88
Disclosure

SEC source: 0000921895-22-001178 · form413392002_04072022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,994,721

F1 · security: This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2950 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F5 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
April 04, 2022 Filed Apr 5, 2022 00:26 UTC Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 122,342 $2.26 $276,309.41
Disclosure

SEC source: 0000921895-22-001091 · form413392002_04042022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,944,993

F1 · security: This Form 4 is filed by the Funicular Fund LP (the "Reporting Person"). The Reporting Person, Cable Car Capital LLC ("Cable Car"), and Jacob Ma-Weaver may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Person, Cable Car and Mr. Ma-Weaver disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.1650 to $2.3050, inclusive of brokerage commissions. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Reporting Person. Cable Car, as the general partner of the Reporting Person, may be deemed to beneficially own the securities directly owned by the Reporting Person. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Reporting Person.

Read SEC document
April 04, 2022 Filed Apr 8, 2022 00:36 UTC Amendment Oruka Therapeutics, Inc. ABIO · Entity 3781 PurchaseCommon Stock 122,342 $2.26 $276,309.41
Disclosure

SEC source: 0000921895-22-001177 · form4a13392002_04072022.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · See Footnote 1

Ma-Weaver Jacob · CIK 0001922140 · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,944,993

F1 · security: This Form 4 is filed by the Funicular Fund LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.1650 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.direct: Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

Read SEC document
October 22, 2020 Filed Oct 22, 2020 23:31 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 SaleCommon stock 772,799 $1.06 $817,621.34
Disclosure

SEC source: 0001752618-20-000028 · primary_doc.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 585,000

Read SEC document
October 21, 2020 Filed Oct 22, 2020 23:31 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 SaleCommon stock 225,000 $1.81 $406,125.00
Disclosure

SEC source: 0001752618-20-000028 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,357,799

F1 · shares: Profits from the sale of 64,032 shares acquired within the preceding six months may be recoverable by the issuer in accordance with the procedures set forth in Section 16(b) of the Securities Exchange Act of 1934.

Read SEC document
October 07, 2020 Filed Oct 8, 2020 21:50 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 14,787 $0.60 $8,875.16
Disclosure

SEC source: 0001752618-20-000027 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,582,799

Read SEC document
September 24, 2020 Filed Sep 24, 2020 22:40 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 2,700 $0.62 $1,672.11
Disclosure

SEC source: 0001752618-20-000026 · primary_doc.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,568,012

Read SEC document
September 23, 2020 Filed Sep 24, 2020 22:40 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 300 $0.60 $180.00
Disclosure

SEC source: 0001752618-20-000026 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,565,312

Read SEC document
September 14, 2020 Filed Sep 14, 2020 20:27 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 8,341 $0.63 $5,250.66
Disclosure

SEC source: 0001752618-20-000025 · primary_doc.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,565,012

Read SEC document
September 11, 2020 Filed Sep 14, 2020 20:27 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 6,700 $0.61 $4,087.00
Disclosure

SEC source: 0001752618-20-000025 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,556,671

Read SEC document
May 21, 2020 Filed May 21, 2020 23:28 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 1,716 $0.65 $1,115.23
Disclosure

SEC source: 0001752618-20-000024 · primary_doc.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,549,971

Read SEC document
May 20, 2020 Filed May 21, 2020 23:28 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 5,870 $0.64 $3,769.13
Disclosure

SEC source: 0001752618-20-000024 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,548,255

Read SEC document
May 19, 2020 Filed May 19, 2020 20:26 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 9,965 $0.64 $6,419.45
Disclosure

SEC source: 0001752618-20-000023 · primary_doc.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,542,385

Read SEC document
May 18, 2020 Filed May 19, 2020 20:26 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 13,604 $0.64 $8,765.06
Disclosure

SEC source: 0001752618-20-000023 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,532,420

Read SEC document
May 07, 2020 Filed May 8, 2020 21:02 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 49 $0.64 $31.36
Disclosure

SEC source: 0001752618-20-000022 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,518,816

Read SEC document
April 15, 2020 Filed Apr 16, 2020 23:57 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 4,700 $0.65 $3,055.00
Disclosure

SEC source: 0001752618-20-000021 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,518,767

Read SEC document
April 13, 2020 Filed Apr 14, 2020 20:57 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 17,200 $0.65 $11,138.72
Disclosure

SEC source: 0001752618-20-000020 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,514,067

Read SEC document
March 26, 2020 Filed Mar 27, 2020 20:42 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 2,556 $0.65 $1,661.40
Disclosure

SEC source: 0001752618-20-000019 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,496,867

Read SEC document
March 25, 2020 Filed Mar 25, 2020 21:20 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 9,707 $0.65 $6,295.96
Disclosure

SEC source: 0001752618-20-000018 · primary_doc.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,494,311

Read SEC document
March 24, 2020 Filed Mar 25, 2020 21:20 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 1,303 $0.64 $830.14
Disclosure

SEC source: 0001752618-20-000018 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,484,604

Read SEC document
March 19, 2020 Filed Mar 20, 2020 23:30 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 100 $0.60 $59.50
Disclosure

SEC source: 0001752618-20-000017 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,483,301

Read SEC document
March 18, 2020 Filed Mar 18, 2020 22:16 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 36,972 $0.63 $23,296.06
Disclosure

SEC source: 0001752618-20-000016 · primary_doc.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,483,201

Read SEC document
March 17, 2020 Filed Mar 18, 2020 22:16 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 26,698 $0.63 $16,921.19
Disclosure

SEC source: 0001752618-20-000016 · primary_doc.xml · nonDerivative · entry 1

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,446,229

Read SEC document
March 16, 2020 Filed Mar 16, 2020 22:15 UTC BLOOMIA HOLDINGS, INC. ISIG · Entity 7768 PurchaseCommon stock 10,233 $0.65 $6,649.40
Disclosure

SEC source: 0001752618-20-000015 · primary_doc.xml · nonDerivative · entry 2

Funicular Fund, LP · CIK 0001752618 · 10% owner

Cable Car Capital LLC · CIK 0001699575 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,419,531

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.